Clinical Trials: Orthostatic Hypotension

Alabaster : Neurology Neurodiagnostic Lab

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Gilbert : Neurological Physicians of Arizona

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Phoenix : Barrow Neurology Clinic

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Phoenix : Xenoscience

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Sun City : Banner Health

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Tucson : Center for Neurosciences

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Glendale : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Laguna Hills : Caring Clinical Research Incorporated

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Newport Beach : Hoag Memorial Hospital, Presbyterian

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Pasadena : Neurosearch - Pasadena

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Reseda : Neurosearch, Inc.

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Ventura : Neurosearch II, Inc.

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Fairfield : Associated Neurologist of Southern Connecticut, PC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Manchester : Eastern Connecticut Neurology Specialists

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Miami : Pharmax Research Clinic, Inc.

Do you have Parkinson's and feel faint when you stand up?

New Port Richey : Advanced Research Institute

A phase 4, randomized-withdrawal, double-blind, placebo-controlled, parallel-group study, to investigate the clinical benefit of Midodrine HCI in Male and Female subjects with symptomatic orthostatic hypotension (SOH).

New Port Richey : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

Pinellas Park : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Boca Raton : Parkinson's Disease & Movement Disorder Disoder

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Miami : Pharmax Research Clinic, LLC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Ormond Beach : Neurology Associates of Ormond Beach

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Port Charlotte : Neurostudies Inc.

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Sarasota : Lovelace Scientific Research

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Tampa : Tampa General University of South Florida

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Vero Beach : Vero Neurology

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

West Palm Beach : Premiere Research Institute

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Atlanta : Emory University

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Elk Grove Village : Alexian Brothers Hospital Network

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Lenexa : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Lenexa : Analab Clinical Research Inc

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Hammond : North Oaks Health System

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Baltimore : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

Baltimore : PAREXEL

Symptomatic Orthostatic Hypotension?

Boston : Harvard Vanguard Medical Associates

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Traverse City : Northern Michigan Neurology

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Ocean Springs : Gulf Coast Neurology Center, PLLC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Las Vegas : University of Nevada School of Medicine

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Hackensack : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Belvidere : Wellness and Research Center

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Lawrenceville : AdvanceMed Research

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Toms River : Shore Neurology

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Buffalo : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Albany : Upstate Clinical Research, LLC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Commack : David L. Kreitzman, M.D., PC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Kingston : Kingston Neurological Associates

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

New Hyde Park : Parker Jewish Institute For Health Care and Rehabilitation Foundation

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

New York : New York University

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

New York : Beth Israel Medical Center

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Syracuse : Neurological Care of CNY

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Greensboro : Guilford Neurologic Associates

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Winston-Salem : Clinical Trials of America Inc

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Cincinnati : Community Research

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Columbus : Ohio State University Medical Center

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Toledo : University of Toledo

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Tulsa : Movement Disorder Clinic of Oklahoma PLLC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Johnstown : Ilumina Clinical Associates

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Pittsburgh : Clinical Trials Research Services LLC

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Knoxville : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Knoxville : New Orleans Center for Clinical Research - Knoxville

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

McKinney : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Dallas : UT Southwestern Medical Center at Dallas

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

McKinney : The Heartbeat Clinic, PA

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

West Orem : MMG

If you are at least 18 years old and have symptomatic orthostatic hypotension (SOH), you may be eligible to participate in one of the STAND studies.

View More »

Orem : Aspen Clinical Research

Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Salt Lake City : JM Neuroscience Research

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Richmond : Neurological Associates, Inc.

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease

Virginia Beach : Sentara Neurology Specialists

Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease